VCYT

VERACYTE, INC.

Name: VERACYTE, INC. insider trading (SEC Form 4) history
Creator: U.S. Securities and Exchange Commission

SEC CIK 1384101

$47.33 +31.1% · 90 days

90-day buys

0 open-market

90-day sells

$9.88M

10 open-market

Net insider flow

−$9.88M

Net selling

Filings shown

Most recent

At a glance

Over the last 90 days, insiders at VCYT have sold a net $9.88M of stock (0 open-market buys vs 10 sells).

Largest recent trade: Stapley Marc sold $6.92M of VCYT, trimming their stake 24%.

Most active filer: Mcguire Annie, with 9 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for VCYT, newest first

View on SEC EDGAR ↗

VCYT

VERACYTE, INC.

Sell McGuire Annie · SVP, General Counsel · Open-market sale · filed Mar 6, 2026 ΔOwn −4.9%

Mcguire Annie sold $176.3K of VCYT, trimming their stake 5%.

−$176.3K

4,994 sh @ $35

VCYT

VERACYTE, INC.

Sell McGuire Annie · SVP, General Counsel · Open-market sale · filed Mar 6, 2026 ΔOwn −1.7%

Mcguire Annie sold $60.5K of VCYT, trimming their stake 2%.

−$60.5K

1,664 sh @ $36

VCYT

VERACYTE, INC.

Tax withholding McGuire Annie · SVP, General Counsel · Tax withholding · filed Mar 4, 2026 ΔOwn −6.4%

−$248.5K

6,902 sh @ $36

VCYT

VERACYTE, INC.

Tax withholding Wygant Jonathan · VP, Chief Accounting Officer · Tax withholding · filed Mar 4, 2026 ΔOwn −7.9%

−$108.2K

3,006 sh @ $36

VCYT

VERACYTE, INC.

Tax withholding Chambers Rebecca · Chief Financial Officer · Tax withholding · filed Mar 4, 2026 ΔOwn −4.6%

−$260.5K

7,234 sh @ $36

VCYT

VERACYTE, INC.

Tax withholding Leite John · Chief Commercial Officer-CLIA · Tax withholding · filed Mar 4, 2026 ΔOwn −6.2%

−$270.7K

7,517 sh @ $36

VCYT

VERACYTE, INC.

Tax withholding Febbo Phillip G. · Chief Scientific & Med Officer · Tax withholding · filed Mar 4, 2026 ΔOwn −4.4%

−$217.3K

6,035 sh @ $36

VCYT

VERACYTE, INC.

Sell Febbo Phillip G. · Chief Scientific & Med Officer · Open-market sale · filed Mar 4, 2026 ΔOwn −10%

Febbo Phillip G. sold $485.4K of VCYT, trimming their stake 10%.

−$485.4K

13,425 sh @ $36

VCYT

VERACYTE, INC.

Sell Wygant Jonathan · VP, Chief Accounting Officer · Open-market sale · filed Nov 12, 2025 ΔOwn −12%

Wygant Jonathan sold $216K of VCYT, trimming their stake 12%.

−$216K

5,102 sh @ $42

VCYT

VERACYTE, INC.

Sell Wygant Jonathan · VP, Chief Accounting Officer · Open-market sale · filed Nov 12, 2025 ΔOwn −12%

Wygant Jonathan sold $233.9K of VCYT, trimming their stake 12%.

−$233.9K

5,818 sh @ $40

VCYT

VERACYTE, INC.

Sell EPSTEIN ROBERT S · Director · Open-market sale · filed Oct 3, 2025 ΔOwn −26%

Epstein Robert S sold $753.2K of VCYT, trimming their stake 26%.

−$753.2K

21,473 sh @ $35

VCYT

VERACYTE, INC.

Sell Wygant Jonathan · VP, Chief Accounting Officer · Open-market sale · filed Dec 4, 2024 ΔOwn −2.3%

Wygant Jonathan sold $41.5K of VCYT, trimming their stake 2%.

−$41.5K

956 sh @ $43

VCYT

VERACYTE, INC.

Sell Wygant Jonathan · VP, Chief Accounting Officer · Open-market sale · filed Nov 29, 2024 ΔOwn −11%

Wygant Jonathan sold $215.8K of VCYT, trimming their stake 11%.

−$215.8K

5,032 sh @ $43

VCYT

VERACYTE, INC.

Sell EPSTEIN ROBERT S · Director · Open-market sale · filed Nov 14, 2024 ΔOwn −25%

Epstein Robert S sold $574.8K of VCYT, trimming their stake 25%.

−$574.8K

15,000 sh @ $38

VCYT

VERACYTE, INC.

Sell EPSTEIN ROBERT S · Director · Open-market sale · filed Jul 14, 2020 ΔOwn −26%

Epstein Robert S sold $73.7K of VCYT, trimming their stake 26%.

−$73.7K

2,563 sh @ $29

VCYT

VERACYTE, INC.

Sell EPSTEIN ROBERT S · Director · Open-market sale · filed Jul 14, 2020 ΔOwn −75%

Epstein Robert S sold $167K of VCYT, trimming their stake 75%.

−$167K

5,583 sh @ $30

VCYT

VERACYTE, INC.

Sell EPSTEIN ROBERT S · Director · Open-market sale · filed Jul 14, 2020 ΔOwn −100%

Epstein Robert S sold $56.6K of VCYT, trimming their stake 100%.

−$56.6K

1,854 sh @ $31

VCYT

VERACYTE, INC.

Sell Cohen Fred E · Director · Open-market sale · filed May 19, 2020 ΔOwn −90%

Cohen Fred E sold $960.3K of VCYT, trimming their stake 90%.

−$960.3K

35,847 sh @ $27

VCYT

VERACYTE, INC.

Sell Cohen Fred E · Director · Open-market sale · filed May 19, 2020 ΔOwn −100%

Cohen Fred E sold $114.2K of VCYT, trimming their stake 100%.

−$114.2K

4,153 sh @ $28

About VCYT insider activity

This page tracks every recent Form 4 filed for VERACYTE, INC. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is VCYT insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for VERACYTE, INC. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.